Article
Washington - Ongoing research indicates neoangiogenesis may have a role as both a novel, powerful prognostic factor for melanoma and an important target for therapeutic strategies aiming to reduce the risk for metastasis, said Robert J. Friedman, M.D., M.Sc.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.